Skip to main content
OpenTrials

Clinical trial condition

Skin and Connective Tissue Diseases

Explore clinical trials studying Skin and Connective Tissue Diseases. Study availability and eligibility vary by location and protocol.

28,259 public trials 4,410 recruiting studies
Refine in advanced search Browse all conditions

Skin and Connective Tissue Diseases trial results

Recruiting

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

NCT06400472

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +42 more
Locations
  • HonorHealth Scottsdale, Arizona, United States
  • University of California, San Diego (UCSD) - Moores Cancer Center La Jolla, California, United States
  • South Texas Accelerated Research Therapeutics (START) Midwest Grand Rapids, Michigan, United States
  • NYU Langone Health - Long Island Mineola, New York, United States
View all 24 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

NCT06617325

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Sl0044 50058 Avondale, Arizona, United States
  • Sl0044 50550 Chandler, Arizona, United States
  • Sl0044 50713 Gilbert, Arizona, United States
  • Sl0044 50662 Glendale, Arizona, United States
View all 242 locations
View Trial Details
Recruiting

Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)

NCT07428499

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +17 more
Locations
  • ADARx Clinical Site Litchfield Park, Arizona, United States
  • ADARx Clinical Site Little Rock, Arkansas, United States
  • ADARx Clinical Site San Diego, California, United States
  • ADARx Clinical Site Walnut Creek, California, United States
View all 48 locations
View Trial Details
Recruiting

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

NCT07287917

Conditions
Breast Diseases, Breast Neoplasms, HER2-low Hormone Receptor Positive Breast Cancer, +13 more
Locations
  • University of Arizona Tucson, Arizona, United States
  • START Los Angeles Los Angeles, California, United States
  • Skin Cancer Institute Englewood, Colorado, United States
  • Wayne State University - Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
View all 20 locations
View Trial Details
Recruiting

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

NCT06857942

Conditions
Body Weight, Nutrition Disorders, Nutritional and Metabolic Diseases, +10 more
Locations
  • Medical Dermatology Specialists Phoenix, Arizona, United States
  • First OC Dermatology Research Inc Fountain Valley, California, United States
  • Center For Dermatology Clinical Research, Inc. Fremont, California, United States
  • Metropolis Dermatology Los Angeles, California, United States
View all 39 locations
View Trial Details

Related conditions